{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:20:06Z","timestamp":1793658006366,"version":"4.5.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.humimm.2026.111681","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T14:19:55Z","timestamp":1770733195000},"page":"111681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preclinical and clinical developments in Treg therapy for heart transplantation: Critical assessment and translational challenges"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-401X","authenticated-orcid":false,"given":"Konstantinos","family":"Mengrelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurenz","family":"Wolner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6791-1128","authenticated-orcid":false,"given":"Rayna Lellis","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Pilat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.humimm.2026.111681_b0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14797\/mdcvj.1580","article-title":"Cardiac Allograft Vasculopathy: a Focus on advances in Diagnosis and Management","volume":"21","author":"Stomberski","year":"2025","journal-title":"Methodist Debakey Cardiovasc. J."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cei\/uxac118","article-title":"The potential for Treg-enhancing therapies in transplantation","volume":"211","author":"Steiner","year":"2023","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2026.111681_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444924","article-title":"The potential of autologous regulatory T cell (Treg) therapy to prevent Cardiac Allograft Vasculopathy (CAV) in paediatric heart transplant recipients","volume":"15","author":"Aiyengar","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2026.111681_b0020","first-page":"723","article-title":"Cell interactions in the induction of tolerance: the role of thymic lymphocytes","volume":"18","author":"Gershon","year":"1970","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.humimm.2026.111681_b0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00007890-199009000-00026","article-title":"Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. IV. Examination of T cell subsets in graft-versus-host assays","volume":"50","author":"Pearce","year":"1990","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.171.1.141","article-title":"Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. further characterization of the CD4+ suppressor cell and its mechanisms of action","volume":"171","author":"Hall","year":"1990","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.humimm.2026.111681_b0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2026.111681_b0040","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.4049\/jimmunol.162.9.5317","article-title":"Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance","volume":"162","author":"Itoh","year":"1999","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2026.111681_b0045","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.4049\/jimmunol.166.6.3789","article-title":"IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo","volume":"166","author":"Hara","year":"2001","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2026.111681_b0050","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.humimm.2026.111681_b0055","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.4049\/jimmunol.168.11.5558","article-title":"Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance","volume":"168","author":"Graca","year":"2002","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.111681_b0060","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.168.3.1080","article-title":"CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses","volume":"168","author":"Kingsley","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2026.111681_b0065","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.4049\/jimmunol.174.6.3290","article-title":"The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen","volume":"174","author":"Bushell","year":"2005","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2026.111681_b0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","article-title":"Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans","volume":"7","author":"Roncarolo","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","article-title":"Harnessing the biology of regulatory T cells to treat disease","volume":"24","author":"Wardell","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"issue":"5609","key":"10.1016\/j.humimm.2026.111681_b0095","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.humimm.2026.111681_b0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fimmu.2015.00395","article-title":"Regulatory T-Cell Development in the Human Thymus","volume":"6","author":"Caramalho","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111681_b0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fimmu.2013.00232","article-title":"Peripherally induced tregs - role in immune homeostasis and autoimmunity","volume":"4","author":"Yadav","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111681_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444533","article-title":"Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense","volume":"15","author":"Yue","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2026.111681_b0115","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.111681_b0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) FoxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2026.111681_b0125","doi-asserted-by":"crossref","unstructured":"Sjogren T, Islam S, Filippov I, Jebrzycka A, Sulen A, Breivik LE, et al. Single cell characterization of blood and expanded regulatory T cells in autoimmune polyendocrine syndrome type 1. iScience. 2024;27(4):109610.","DOI":"10.1016\/j.isci.2024.109610"},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-6143.2011.03770.x","article-title":"Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance","volume":"12","author":"Zhao","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-6143.2010.03389.x","article-title":"Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function","volume":"11","author":"Lal","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"11 Suppl","key":"10.1016\/j.humimm.2026.111681_b0140","first-page":"S187","article-title":"Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion","volume":"124","author":"Itoh","year":"2011","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.humimm.2026.111681_b0145","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1084\/jem.20081937","article-title":"A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy","volume":"205","author":"Yuan","year":"2008","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0150","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/s41467-024-48574-w","article-title":"IL-6 inhibition prevents costimulation blockade-resistant allograft rejection in T cell-depleted recipients by promoting intragraft immune regulation in mice","volume":"15","author":"Muckenhuber","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111681_b0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ajt.17206","article-title":"Targeting IL-6 to prevent cardiac allograft rejection","volume":"22 Suppl 4(Suppl 4)","author":"Miller","year":"2022","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007890-197310000-00010","article-title":"Primarily vascularized allografts of hearts in mice. the role of H-2D, H-2K, and non-H-2 antigens in rejection","volume":"16","author":"Corry","year":"1973","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2026.111681_b0165","article-title":"Murine cervical heart transplantation model using a modified cuff technique","volume":"92","author":"Oberhuber","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0170","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2006-05-025460","article-title":"In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance","volume":"109","author":"Golshayan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111681_b0175","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.3389\/ti.2024.13196","article-title":"Activation and Regulation of indirect Alloresponses in Transplanted patients with Donor specific Antibodies and Chronic rejection","volume":"37","author":"Basu","year":"2024","journal-title":"Transpl. Int."},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.trim.2009.05.003","article-title":"Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression","volume":"21","author":"Tsang","year":"2009","journal-title":"Transpl. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1600-6143.2010.03018.x","article-title":"Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning","volume":"10","author":"Pilat","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.healun.2013.11.004","article-title":"T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model","volume":"33","author":"Pilat","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.humimm.2026.111681_b0200","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85911","article-title":"Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization","volume":"1","author":"Pilat","year":"2016","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.humimm.2026.111681_b0205","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/ajt.15212","article-title":"Prolongation of allograft survival by passenger donor regulatory T cells","volume":"19","author":"Harper","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2026.111681_b0210","article-title":"Inhibition of thrombin on endothelium enhances recruitment of regulatory T cells during IRI and when combined with adoptive Treg transfer, significantly protects against acute tissue injury and prolongs allograft survival","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0000000000004707","article-title":"IL-35 Stabilizes Treg Phenotype to Protect Cardiac Allografts in mice","volume":"108","author":"Huang","year":"2024","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/acs.2018.01.07","article-title":"Current state of pediatric cardiac transplantation","volume":"7","author":"Dipchand","year":"2018","journal-title":"Ann Cardiothorac Surg."},{"issue":"10","key":"10.1016\/j.humimm.2026.111681_b0225","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.healun.2019.08.002","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match","volume":"38","author":"Rossano","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"10.1016\/j.humimm.2026.111681_b0230","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/01.tp.0000265446.61754.d2","article-title":"Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo","volume":"83","author":"Warnecke","year":"2007","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.humimm.2026.111681_b0235","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nm.2154","article-title":"In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells","volume":"16","author":"Nadig","year":"2010","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.humimm.2026.111681_b0240","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1600-6143.2012.04065.x","article-title":"Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo","volume":"12","author":"Hester","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"23","key":"10.1016\/j.humimm.2026.111681_b0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173593","article-title":"Dysregulated Treg repair responses lead to chronic rejection after heart transplantation","volume":"134","author":"Warunek","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2026.111681_b0250","doi-asserted-by":"crossref","first-page":"14958","DOI":"10.3389\/ti.2025.14958","article-title":"Tolerance Induction strategies in Organ Transplantation: Current Status and Future Perspectives","volume":"38","author":"Blein","year":"2025","journal-title":"Transpl. Int."},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0260","article-title":"Cellular Therapies in Transplantation - Regulatory T Cell Therapies and Virus specific Therapies","volume":"12","author":"Hannouneh","year":"2025","journal-title":"Curr Transplant Rep."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0265","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.humimm.2026.111681_b0270","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1097\/TP.0000000000003149","article-title":"A Clinical Trial with Adoptive transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation-a Second Report","volume":"104","author":"Koyama","year":"2020","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.humimm.2026.111681_b0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1665-2681(19)31551-0","article-title":"Operational tolerance after liver transplantation, more common than we think: a case report","volume":"10","author":"Benitez","year":"2011","journal-title":"Ann. Hepatol."},{"issue":"6","key":"10.1016\/j.humimm.2026.111681_b0280","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1600-6143.2012.04035.x","article-title":"A need for biomarkers of operational tolerance in liver and kidney transplantation","volume":"12","author":"Londono","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.humimm.2026.111681_b0285","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00392-023-02341-x","article-title":"Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational tolerance","volume":"113","author":"von Scheidt","year":"2024","journal-title":"Clin. Res. Cardiol."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021752","article-title":"Treg Therapy for the Induction of Immune Tolerance in Transplantation-not lost in translation?","volume":"24","author":"Pilat","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111681_b0295","article-title":"Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial","author":"Meyer","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111681_b0300","article-title":"Study protocol: phase I\/II trial of induced HLA-G(+) regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor","volume":"10","author":"Lysandrou","year":"2023","journal-title":"Front Med (lausanne)."},{"key":"10.1016\/j.humimm.2026.111681_b0305","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/562935","article-title":"Polyclonal Recipient nTregs are Superior to Donor or Third-Party Tregs in the Induction of Transplantation Tolerance","volume":"2015","author":"Pilat","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2026.111681_b0310","article-title":"213.2: Preliminary results of the first Clinical Trial to prevent Graft rejection in Heart Transplant Children Employing a Cellular Therapy with Autologous Treg Obtained from Thymic Tissue (thyTreg)","volume":"106(9S):S28","author":"Bernaldo-de-Quir\u00f3s","year":"2022","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.humimm.2026.111681_b0315","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231045","article-title":"First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant","volume":"220","author":"Bernaldo-de-Quiros","year":"2023","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.humimm.2026.111681_b0320","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13930","article-title":"T cell phenotype in paediatric heart transplant recipients","volume":"25","author":"Mengrelis","year":"2021","journal-title":"Pediatr. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0325","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded Human Thymus is a Novel source of Stable and Long-Lived Therapeutic Regulatory T Cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2026.111681_b0330","article-title":"Unlocking the therapeutic potential of thymus-isolated regulatory T cells","volume":"16","author":"Hu","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2026.111681_b0335","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/eji.202048949","article-title":"Isolation and expansion of thymus-derived regulatory T cells for use in pediatric heart transplant patients","volume":"51","author":"Romano","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2026.111681_b0340","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtm.2018.01.006","article-title":"A Rapamycin-based GMP-Compatible Process for the Isolation and expansion of Regulatory T Cells for Clinical Trials","volume":"8","author":"Fraser","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0345","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/TP.0000000000001278","article-title":"CD45RA Distinguishes CD4+CD25+CD127-\/low TSDR Demethylated Regulatory T Cell Subpopulations with Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of suppression","volume":"101","author":"Arroyo Hornero","year":"2017","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0350","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/gutjnl-2014-306919","article-title":"Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease","volume":"65","author":"Canavan","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0355","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12967-025-06561-9","article-title":"Clinical grade expansion protocol for the manufacture of thymus-derived Treg cells for clinical application","volume":"23","author":"Fanelli","year":"2025","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.humimm.2026.111681_b0360","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1097\/TXD.0000000000001152","article-title":"The Presence of a Marked Imbalance between Regulatory T Cells and Effector T Cells reveals that Tolerance Mechanisms could Be Compromised in Heart Transplant Children","volume":"7","author":"Bernaldo-de-Quiros","year":"2021","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.humimm.2026.111681_b0365","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.787975","article-title":"Post-transplant Lymphoproliferative Disorder following Cardiac Transplantation","volume":"9","author":"Asleh","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.humimm.2026.111681_b0370","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/infdis\/156.2.273","article-title":"Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation","volume":"156","author":"Breinig","year":"1987","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.humimm.2026.111681_b0375","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-079582","article-title":"Immunology of THymectomy and childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised children","volume":"13","author":"Offor","year":"2023","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.humimm.2026.111681_b0380","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","article-title":"Thymus transplantation for complete DiGeorge syndrome: European experience","volume":"140","author":"Davies","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111681_b0385","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201747193","article-title":"Transplanted human thymus slices induce and support T-cell development in mice after cryopreservation","volume":"48","author":"Ross","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.111681_b0390","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","article-title":"Recent advances and discoveries in the mechanisms and functions of CAR T cells","volume":"21","author":"Larson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.humimm.2026.111681_b0395","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3389\/fimmu.2019.02250","article-title":"Engineered T Cell Therapy for Cancer in the Clinic","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111681_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gendis.2021.07.001","article-title":"Anti-C4d chimeric antigen receptor regulatory T cells suppressed allograft rejection in ABO-incompatible heart transplantation","volume":"9","author":"Lee","year":"2022","journal-title":"Genes Dis."},{"issue":"9","key":"10.1016\/j.humimm.2026.111681_b0405","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/ajt.17063","article-title":"Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival","volume":"22","author":"Wagner","year":"2022","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.humimm.2026.111681_b0410","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.188624","article-title":"CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance","volume":"10","author":"Durgam","year":"2025","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.humimm.2026.111681_b0415","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1016\/j.ajt.2025.07.589","article-title":"STEADFAST Study Update: a phase 1\/2 Clinical Trial of Regulatory T Cells Expressing a Chimeric Antigen Receptor Directed Towards HLA-A2 in Renal Transplantation","volume":"25","author":"Schreeb","year":"2025","journal-title":"Am. J. Transplant."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:27:09Z","timestamp":1781857629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0198885926000273"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111681","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical and clinical developments in Treg therapy for heart transplantation: Critical assessment and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"111681"}}